ReviewInternational journal of medical sciences2026
STATs Signaling Pathways in Acute Pancreatitis: Mechanisms and Regulation.
Review in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute pancreatitis (AP) is a potentially life-threatening inflammatory disorder of the pancreas that can progress from local injury to systemic inflammatory response and multi-organ dysfunction. Despite improvements in supportive treatment, there is still no effective drug therapy for AP. This highlights the necessity of clarifying its molecular mechanisms and exploring novel therapeutic strategies. Among the diverse signaling pathways implicated in the pathogenesis of AP, the significance of the signal transducer and activator of transcription (STAT) family has become increasingly evident. Building on the increasing recognition of the STATs family in AP, this review provides a systematic synthesis in three domains. The first addresses mechanistic studies of STATs-related signaling, the second focuses on pharmacological regulation with an emphasis on natural products and chemical drugs, and the third explores clinical evidence connecting STATs activity to severity and outcomes of AP. By synthesizing mechanistic, pharmacological, and clinical evidence, this review highlights the central role of STATs family members in AP. It underscores the therapeutic potential of natural medicines in targeting STATs pathways and suggests directions for future translational studies to develop effective interventions for AP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.